Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related TEVA
Breaking Down The Multiple Sclerosis 2017 Formularies: 'Stability Fares Well For The Market'
The Market In 5 Minutes
Stock Rankings According To Hedge Fund Investing (Part 23) (Seeking Alpha)
Related QEP
Benzinga's Option Alert Recap From January 26
Watch These 8 Huge Put Purchases In Thursday Trade
QEP Resources (QEP) Q4 2016 Results - Earnings Call Transcript (Seeking Alpha)

Analysts at JP Morgan downgraded Teva Pharmaceutical Industries (NYSE: TEVA) from “overweight” to “neutral.” The target price for Teva has been lowered from $45 to $43. Teva's shares closed at $38.88 yesterday.

Deutsche Bank downgraded QEP Resources (NYSE: QEP) from “buy” to “hold.” The target price for QEP Resources has been lowered from $37 to $34. QEP Resources' shares closed at $28.78 yesterday.

Baird downgraded Brady (NYSE: BRC) from “outperform” to “neutral.” The target price for Brady has been lowered from $41 to $33. Brady's shares closed at $30.52 yesterday.

Analysts at DA Davidson downgraded Under Armour (NYSE: UA) from “buy” to “neutral.” Under Armour's shares closed at $80.59 yesterday.

Latest Ratings for TEVA

DateFirmActionFromTo
Feb 2017MizuhoDowngradesNeutralUnderperform
Jan 2017Bank of AmericaUpgradesNeutralBuy
Jan 2017JP MorganDowngradesOverweightNeutral

View More Analyst Ratings for TEVA
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (BRC + QEP)

View Comments and Join the Discussion!